Physical Activity and Fatigue in Early Multiple Sclerosis (MS)

CompletedOBSERVATIONAL
Enrollment

1,739

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Multiple Sclerosis
Interventions
DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

Intravenous therapy according to product information

Trial Locations (33)

Unknown

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY